Stocks and Investing
Stocks and Investing
Mon, September 16, 2024
[ Mon, Sep 16th 2024
] - WOPRAI
[ Mon, Sep 16th 2024
] - WOPRAI
[ Mon, Sep 16th 2024
] - WOPRAI
[ Mon, Sep 16th 2024
] - WOPRAI
Fri, September 13, 2024
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
[ Fri, Sep 13th 2024
] - WOPRAI
Jonathan Wolleben Maintained (AURA) at Buy with Increased Target to $23 on, Sep 13th, 2024
Jonathan Wolleben of JMP Securities, Maintained "Aura Biosciences, Inc." (AURA) at Buy with Increased Target from $19 to $23 on, Sep 13th, 2024.
Jonathan, nor any peers, have made any analyst calls on AURA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources